| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | 0.042 | 0.2 |
| mRNA | BRD-K70511574 | CTRPv2 | pan-cancer | AAC | 0.045 | 0.2 |
| mRNA | PRIMA-1-Met | CTRPv2 | pan-cancer | AAC | -0.08 | 0.2 |
| mRNA | PIK-93 | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | navitoclax:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.045 | 0.2 |
| mRNA | BRD-K30748066 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.2 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.061 | 0.2 |
| mRNA | foretinib | CTRPv2 | pan-cancer | AAC | -0.046 | 0.2 |
| mRNA | dexamethasone | CTRPv2 | pan-cancer | AAC | -0.044 | 0.2 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | 0.069 | 0.2 |